Peptide Report
NAD+ Peptide Report
Catalog report for NAD+, generated from Peptide Stacks product data and linked to the matching PeptideReports protocol page when available.
Current Price$49.99 – $79.99 CAD
Common Uses
People commonly use NAD+ in cellular-energy, healthy-aging, recovery, and wellness routines, with interest often focused on energy, resilience, and metabolic support.
How It Works
NAD+ is not a peptide; it is a central redox coenzyme. It works by cycling between NAD+ and NADH in energy metabolism and also serves as a substrate for enzymes such as sirtuins and PARPs involved in repair and stress-response signaling.
Storage
Powder form: In lyophilized powder form, NAD+ is generally kept sealed, dry, protected from direct light, and refrigerated unless the product label or certificate of analysis gives different handling instructions. Avoid leaving vials in hot rooms, vehicles, direct sunlight, or other temperature swings, because moisture, heat, and light are the main storage conditions people try to control before reconstitution.
Reconstituted: After reconstitution, NAD+ should generally be treated as more sensitive: keep it refrigerated, minimize unnecessary handling, avoid shaking, and use clean handling practices each time the vial is accessed. Follow the product label, protocol page, and any pharmacy or lab guidance for beyond-use timing; if the solution changes color, becomes cloudy, develops particles, or the vial integrity is questionable, it should not be used.
Protocol
The full NAD+ 500mg protocol is included below. The standalone protocol page remains available if you want to open it separately.
Open Standalone Protocol
Scope
Preparation examples, syringe conversion, gradual community-reported patterns and evidence limitations.
Available strengths: 500 MG and 1000 MG
Preparation Examples
These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.
| Setup |
Diluent |
Concentration |
Unit conversion |
| 500 MG vial example |
Add 2.5 mL bacteriostatic water |
200 mg/mL |
Each U-100 unit = 2 mg |
| 1000 MG vial example |
Add 5.0 mL if vial capacity allows |
200 mg/mL |
Each U-100 unit = 2 mg |
Syringe Conversion
| Reported amount |
500 MG setup |
1000 MG setup |
| 20 mg |
10 units |
10 units |
| 40 mg |
20 units |
20 units |
| 60 mg |
30 units |
30 units |
| 100 mg |
50 units |
50 units |
Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.
Community-Reported Patterns
Anecdotal summary of the cited community discussions. These observations are descriptive, not a recommendation or evidence of safety or efficacy.
| Recurring report |
Frequency seen |
Context in reports |
| 20-40 mg |
One to three times weekly |
Lower-start reports |
| 40-100 mg |
Two to three times weekly |
Most recurring range |
| 100 mg or more |
Intermittent in some reports |
Higher experimental use |
Observations
- Community discussions most often centered on energy, mental clarity and recovery from fatigue.
- Gradual increases from 20 mg toward 100 mg appeared more often than beginning at the highest reported amount.
- The 500 MG and 1000 MG examples use the same concentration, so syringe conversion remains identical.
Caveats
- Direct human evidence for subcutaneous NAD+ schedules is limited, and community reports do not establish an appropriate dose or benefit.
- Vial capacity must be confirmed before adding 5 mL. If a different volume is used, the concentration and syringe conversion must be recalculated.